Literature DB >> 15876927

Duration of immunity against pertussis after natural infection or vaccination.

Aaron M Wendelboe1, Annelies Van Rie, Stefania Salmaso, Janet A Englund.   

Abstract

Despite decades of high vaccination coverage, pertussis has remained endemic and reemerged as a public health problem in many countries in the past 2 decades. Waning of vaccine-induced immunity has been cited as one of the reasons for the observed epidemiologic trend. A review of the published data on duration of immunity reveals estimates that infection-acquired immunity against pertussis disease wanes after 4-20 years and protective immunity after vaccination wanes after 4-12 years. Further research into the rate of waning of vaccine-acquired immunity will help determine the optimal timing and frequency of booster immunizations and their role in pertussis control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876927     DOI: 10.1097/01.inf.0000160914.59160.41

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  174 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

Review 2.  Vaccination recommendations for Germany.

Authors:  Miriam Wiese-Posselt; Christine Tertilt; Fred Zepp
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

3.  Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Authors:  Mohammed-Jafar Saffar; Ali-Reza Khalilian; Ali-Reza Rafee; Mohammed Reza Parsaei; Shadi Imanikhani; Jalil Shojaei; Hana Saffar
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

4.  Modelling the long-term dynamics of pre-vaccination pertussis.

Authors:  Ganna Rozhnova; Ana Nunes
Journal:  J R Soc Interface       Date:  2012-06-20       Impact factor: 4.118

5.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

Review 6.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

Review 7.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

8.  Clinical characteristics and pertussis costs in cases reported to epidemiological services and cases detected in household contacts in Catalonia (Spain).

Authors:  P Plans; C Muñoz-Almagro; P Godoy; M Jané; G Carmona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

Review 9.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

Review 10.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.